Abstract
(Abstracted from Fertil Steril 2020;114:321–330 There exists considerable variation in patient’s response to gonadotropin stimulation when undergoing assisted reproductive technologies (ARTs). Serum anti-Müllerian hormone (AMH) level has been shown to be a robust predictor of ovarian response and is used to guide gonadotropin dosing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
